-
1
-
-
33745209036
-
Post-operative use of heparin increases morbidity of pacemaker implantation
-
C. Marquie, G. De Geeter, and D. Klug Post-operative use of heparin increases morbidity of pacemaker implantation Europace 8 4 2006 283 287
-
(2006)
Europace
, vol.8
, Issue.4
, pp. 283-287
-
-
Marquie, C.1
De Geeter, G.2
Klug, D.3
-
2
-
-
1542610717
-
Pacemaker and implantable cardioverter-defibrillator implantation without reversal of warfarin therapy
-
M.C. Giudici, D.L. Paul, P. Bontu, and S.S. Barold Pacemaker and implantable cardioverter-defibrillator implantation without reversal of warfarin therapy Pacing Clin Electrophysiol 27 3 2004 358 360
-
(2004)
Pacing Clin Electrophysiol
, vol.27
, Issue.3
, pp. 358-360
-
-
Giudici, M.C.1
Paul, D.L.2
Bontu, P.3
Barold, S.S.4
-
3
-
-
46049099373
-
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)
-
J.D. Douketis, P.B. Berger, and A.S. Dunn The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 6 Suppl. 2008 299S 339S
-
(2008)
Chest
, vol.133
, Issue.6 SUPPL.
-
-
Douketis, J.D.1
Berger, P.B.2
Dunn, A.S.3
-
4
-
-
84856804836
-
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
J.D. Douketis, A.C. Spyropoulos, and F.A. Spencer Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl. 2012 e326S e350S
-
(2012)
Chest
, vol.141
, Issue.2 SUPPL.
-
-
Douketis, J.D.1
Spyropoulos, A.C.2
Spencer, F.A.3
-
6
-
-
0037250417
-
Implantation of pacemakers and implantable cardioverter-defibrillators in orally anticoagulated patients
-
A.S. al-Khadra Implantation of pacemakers and implantable cardioverter-defibrillators in orally anticoagulated patients Pacing Clin Electrophysiol 26 1 Pt 2 2003 511 514
-
(2003)
Pacing Clin Electrophysiol
, vol.26
, Issue.1 PART 2
, pp. 511-514
-
-
Al-Khadra, A.S.1
-
7
-
-
67650541562
-
Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin
-
A. Tischenko, L.J. Gula, R. Yee, G.J. Klein, A.C. Skanes, and A.D. Krahn Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin Am Heart J 158 2 2009 252 256
-
(2009)
Am Heart J
, vol.158
, Issue.2
, pp. 252-256
-
-
Tischenko, A.1
Gula, L.J.2
Yee, R.3
Klein, G.J.4
Skanes, A.C.5
Krahn, A.D.6
-
8
-
-
77952572898
-
Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation
-
I. Ahmed, E. Gertner, and W.B. Nelson Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 6 2010 745 749
-
(2010)
Heart Rhythm
, vol.7
, Issue.6
, pp. 745-749
-
-
Ahmed, I.1
Gertner, E.2
Nelson, W.B.3
-
9
-
-
84868204325
-
Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices
-
H. Ghanbari, W.S. Phard, and H. Al-Ameri Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices Am J Cardiol 110 10 2012 1482 1488
-
(2012)
Am J Cardiol
, vol.110
, Issue.10
, pp. 1482-1488
-
-
Ghanbari, H.1
Phard, W.S.2
Al-Ameri, H.3
-
10
-
-
77952217479
-
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation
-
C. Tompkins, A. Cheng, and D. Dalal Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation J Am Coll Cardiol 55 21 2010 2376 2382
-
(2010)
J Am Coll Cardiol
, vol.55
, Issue.21
, pp. 2376-2382
-
-
Tompkins, C.1
Cheng, A.2
Dalal, D.3
-
11
-
-
0034036119
-
A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation
-
G.F. Michaud, F. Pelosi, M.D. Noble, B.P. Knight, F. Morady, and S.A. Strickberger A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation J Am Coll Cardiol 35 7 2000 1915 1918
-
(2000)
J Am Coll Cardiol
, vol.35
, Issue.7
, pp. 1915-1918
-
-
Michaud, G.F.1
Pelosi, F.2
Noble, M.D.3
Knight, B.P.4
Morady, F.5
Strickberger, S.A.6
-
12
-
-
68749100861
-
Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: Oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial
-
J.M. Tolosana, P. Berne, and L. Mont Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial Eur Heart J 30 15 2009 1880 1884
-
(2009)
Eur Heart J
, vol.30
, Issue.15
, pp. 1880-1884
-
-
Tolosana, J.M.1
Berne, P.2
Mont, L.3
-
13
-
-
45349095265
-
Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment
-
P. Karjalainen, S. Vikman, and M. Niemelä Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment Eur Heart J 29 8 2008 1001 1010
-
(2008)
Eur Heart J
, vol.29
, Issue.8
, pp. 1001-1010
-
-
Karjalainen, P.1
Vikman, S.2
Niemelä, M.3
-
14
-
-
80055096547
-
Safety of coronary artery bypass surgery during therapeutic oral anticoagulation
-
K.E. Airaksinen, F. Biancari, and P. Karjalainen Safety of coronary artery bypass surgery during therapeutic oral anticoagulation Thromb Res 128 5 2011 435 439
-
(2011)
Thromb Res
, vol.128
, Issue.5
, pp. 435-439
-
-
Airaksinen, K.E.1
Biancari, F.2
Karjalainen, P.3
-
15
-
-
77953011912
-
Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: A prospective study
-
P. Korkeila, P. Mustonen, and J. Koistinen Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study Europace 12 6 2010 817 824
-
(2010)
Europace
, vol.12
, Issue.6
, pp. 817-824
-
-
Korkeila, P.1
Mustonen, P.2
Koistinen, J.3
-
16
-
-
77957699729
-
Surgery EAfC-T. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
-
A.J. Camm, P. Kirchhof, and G.Y. Lip Surgery EAfC-T. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2010 2369 2429
-
(2010)
Eur Heart J
, vol.31
, Issue.19
, pp. 2369-2429
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
-
17
-
-
84866698766
-
Periprocedural heparin bridging in patients receiving vitamin K antagonists: Systematic review and meta-analysis of bleeding and thromboembolic rates
-
D. Siegal, J. Yudin, S. Kaatz, J.D. Douketis, W. Lim, and A.C. Spyropoulos Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates Circulation 126 13 2012 1630 1639
-
(2012)
Circulation
, vol.126
, Issue.13
, pp. 1630-1639
-
-
Siegal, D.1
Yudin, J.2
Kaatz, S.3
Douketis, J.D.4
Lim, W.5
Spyropoulos, A.C.6
-
18
-
-
79952202650
-
How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: To "bridge" or not to "bridge"?
-
K. Airaksinen, A. Schlitt, A. Rubboli, P. Karjalainen, and G. Lip How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"? EuroIntervention 6 4 2010 520 526
-
(2010)
EuroIntervention
, vol.6
, Issue.4
, pp. 520-526
-
-
Airaksinen, K.1
Schlitt, A.2
Rubboli, A.3
Karjalainen, P.4
Lip, G.5
-
19
-
-
79955441513
-
Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment
-
A. Hakalahti, P. Uusimaa, K. Ylitalo, and M.J. Raatikainen Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment Europace 13 5 2011 640 645
-
(2011)
Europace
, vol.13
, Issue.5
, pp. 640-645
-
-
Hakalahti, A.1
Uusimaa, P.2
Ylitalo, K.3
Raatikainen, M.J.4
-
20
-
-
84857652113
-
Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices
-
O. Cano, B. Muñoz, and D. Tejada Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices Heart Rhythm 9 3 2012 361 367
-
(2012)
Heart Rhythm
, vol.9
, Issue.3
, pp. 361-367
-
-
Cano, O.1
Muñoz, B.2
Tejada, D.3
-
21
-
-
81855194797
-
Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices
-
P. Korantzopoulos, K.P. Letsas, T. Liu, N. Fragakis, M. Efremidis, and J.A. Goudevenos Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices Europace 13 12 2011 1669 1680
-
(2011)
Europace
, vol.13
, Issue.12
, pp. 1669-1680
-
-
Korantzopoulos, P.1
Letsas, K.P.2
Liu, T.3
Fragakis, N.4
Efremidis, M.5
Goudevenos, J.A.6
-
22
-
-
52449134909
-
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: A systematic review and practical management guide
-
E. Jamula, J. Douketis, and S. Schulman Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide J Thromb Haemost 6 10 2008 1615 1621
-
(2008)
J Thromb Haemost
, vol.6
, Issue.10
, pp. 1615-1621
-
-
Jamula, E.1
Douketis, J.2
Schulman, S.3
-
23
-
-
79953239765
-
Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial
-
A. Cheng, S. Nazarian, and J.A. Brinker Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial Heart Rhythm 8 4 2011 536 540
-
(2011)
Heart Rhythm
, vol.8
, Issue.4
, pp. 536-540
-
-
Cheng, A.1
Nazarian, S.2
Brinker, J.A.3
-
24
-
-
84861733232
-
Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry
-
H. Lahtela, A. Rubboli, and A. Schlitt Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry Circ J 76 6 2012 1363 1368
-
(2012)
Circ J
, vol.76
, Issue.6
, pp. 1363-1368
-
-
Lahtela, H.1
Rubboli, A.2
Schlitt, A.3
-
25
-
-
0035125405
-
Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
-
J. Hirsh, T. Warkentin, and S. Shaughnessy Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety Chest 119 1 Suppl. 2001 64S 94S
-
(2001)
Chest
, vol.119
, Issue.1 SUPPL.
-
-
Hirsh, J.1
Warkentin, T.2
Shaughnessy, S.3
-
26
-
-
33845323043
-
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
-
H. White, N. Kleiman, and K. Mahaffey Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial Am Heart J 152 6 2006 1042 1050
-
(2006)
Am Heart J
, vol.152
, Issue.6
, pp. 1042-1050
-
-
White, H.1
Kleiman, N.2
Mahaffey, K.3
-
27
-
-
0025326059
-
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis
-
R. Hull, G. Raskob, and D. Rosenbloom Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis N Engl J Med 322 18 1990 1260 1264
-
(1990)
N Engl J Med
, vol.322
, Issue.18
, pp. 1260-1264
-
-
Hull, R.1
Raskob, G.2
Rosenbloom, D.3
|